Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dr. Reddy's Laboratories Ltd Common Stock (RDY) vs Solaris Energy Infrastructure Inc. Class A Common Stock (SEI) Price & Performance

Dr. Reddy's Laboratories Ltd Common StockTrade
Solaris Energy Infrastructure Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Dr. Reddy's Laboratories Ltd Common Stock vs Solaris Energy Infrastructure Inc. Class A Common Stock — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while Solaris Energy Infrastructure Inc. Class A Common Stock trades at $68.5 (market cap $5.12B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 2.1× Solaris Energy Infrastructure Inc. Class A Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays the higher dividend (0.65%). Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Solaris Energy Infrastructure Inc. Class A Common Stock for 0 Days on average.

RDYSEI
Market Cap
$10.78B$5.12B
Volume
2,724,3432,532,496
Sector
HealthEnergy
52-Week High
$15.38$82.88
52-Week Low
$11.38$40.64
Typical Hold Time
0 Days0 Days
Enterprise Value
$10.68B$6.81B
Dividend Yield
0.65%0.62%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Solaris Energy Infrastructure Inc. Class A Common Stock

SEI (Solaris Energy Infrastructure) trades at $77.83, down 1.83% today, but maintains strong analyst support with 9 unanimous buy ratings and a $100.56 consensus price target. The stock shows positive momentum with three consecutive quarterly earnings beats and projected revenue growth from $622M in 2025 to $762M in 2026. Recent technical analysis indicates neutral signals with support at $76 and resistance at $79.

The outlook remains positive given strong earnings performance and expansion initiatives, though elevated valuation ratios (P/E of 98.52) and significant debt issuance ($1.25B notes) present risks. The upcoming Q3 2026 earnings report on October 21 will be crucial for validating growth trajectory amid energy sector volatility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RDY
100% Buy0% Sell
Avg holding period · 0 Days
SEI
100% Buy0% Sell
Avg holding period · 0 Days

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →

About Solaris Energy Infrastructure Inc. Class A Common Stock

Solaris Energy Infrastructure, Inc. provides mobile power generation, control, and distribution equipment and logistics equipment for managing raw materials at well sites, operating through its Solaris Power Solutions and Solaris Logistics Solutions segments for data center, energy, commercial, and industrial customers.

Read more on SEI →